Mon, December 19, 2022

Michael King Initiated (SONN) at Strong Buy on, Dec 19th, 2022

Michael King of EF Hutton, Initiated "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy on, Dec 19th, 2022.

Michael has made no other calls on SONN in the last 4 months.



There is 1 other peer that has a rating on SONN. Out of the 1 peers that are also analyzing SONN, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy on, Thursday, September 22nd, 2022